Wal-Mart will participate in the blockchain drug tracking pilot program with KPMG and pharmaceutical manufacturer Merck

According to CoinDesk, Wal-Mart announced on June 13 that it will participate in the blockchain drug tracking pilot program with KPMG and pharmaceutical manufacturer Merck. Earlier on June 3, Wal-Mart joined the MediLedger Blockchain Alliance, which is used to track the source of drugs.